Comparative structural analyses of selected spike protein-RBD mutations in SARS-CoV-2 lineages

AbstractThe severity of COVID-19 has been observed throughout the world as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) globally claimed more than 2 million lives and left a devastating impact worldwide. Recently several virulent mutant strains of this virus, such as the B.1.1.7, B.1.351, and P1 lineages, have emerged with initial predominance in UK, South Africa, and Brazil. Another extremely pathogenic B.1.617 lineage and its sub-lineages, first detected in India, are now affecting some countries at notably stronger spread-rates. The present paper computationally examines the time-based structures of B.1.1.7, B.1.351, and P1 lineages with selected spike protein mutations. The mutations in the more recently found B.1.617 lineage and its sub-lineages are explored, and the implications for multiple point mutations of the spike protein ’s receptor-binding domain (RBD) are described. The selected S1 mutations within the highly contagious B.1.617.2 sub-lineage, also known as the delta variant, are examined as well.
Source: Immunologic Research - Category: Allergy & Immunology Source Type: research

Related Links:

This report describes COVID-19 vaccine effectiveness time frames among people who received their first and second doses of the vaccine series, and effectiveness of third vaccine doses during both Delta- and Omicron-predominant periods.
Source: CDC Morbidity and Mortality Weekly Report - Category: American Health Tags: Adult Health Coronavirus [CoV] Hospitalization rates MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Vaccination Vaccines COVID-19 Source Type: news
Condition:   COVID-19 Intervention:   Diagnostic Test: real time PCR Sponsor:   Sohag University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
This report describes COVID-19 incidence rate ratios for unvaccinated versus fully vaccinated persons with and without booster vaccine doses during the emergence of the Omicron variant.
Source: CDC Morbidity and Mortality Weekly Report - Category: American Health Tags: Adult Health Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Vaccination Vaccines Death Rates COVID-19 Source Type: news
Int J Mol Med. 2022 Mar;49(3):33. doi: 10.3892/ijmm.2022.5088. Epub 2022 Jan 21.ABSTRACTThe pandemic caused by the severe acute respiratory syndrome coronavirus (SARS‑CoV‑2), responsible for coronavirus disease 2019 (COVID‑19) has posed a major challenge for global health. In order to successfully combat SARS‑CoV‑2, the development of effective COVID‑19 vaccines is crucial. In this context, recent studies have highlighted a high COVID‑19 mortality rate in patients affected by β‑thalassemia, probably due to their co‑existent immune deficiencies. In addition to a role in the severity of SARS‑CoV‑2 ...
Source: Molecular Medicine - Category: Molecular Biology Authors: Source Type: research
INTRODUCTION: In April 2020, novel coronavirus SARS-Co-V-2 (COVID-19) produced an ongoing mass fatality event in New York. This overwhelmed hospital morgues necessitating emergent expansion of capacity in the form of refrigerated trucks, trailers, and ship...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Disaster Preparedness Source Type: news
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly pathogenic and contagious coronavirus that caused a global pandemic with 5.2 million fatalities. Questions concerning serological features of long-term immunity, especially dominant epitopes mediating durable antibody responses after SARS-CoV-2 infection, still remain to be elucidated.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research
AbstractSince the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more and more atypical presentations of COVID-19 are being reported. Here, we present and discuss non-convulsive status epilepticus (NCSE) as presenting symptom of SARS-CoV-2 infection at the Emergency Department.
Source: International Journal of Emergency Medicine - Category: Emergency Medicine Source Type: research
AbstractPurpose of ReviewPrior to the SARS-CoV-2 novel coronavirus (COVID-19) pandemic, access and utilization of telemedicine in the USA was negligeable, with very little interest from both the public and healthcare sectors. Since that time, telemedicine technology and services have undergone explosive growth and investment and are poised to change the way healthcare is delivered now and in the future. But has telemedicine truly changed the way healthcare is delivered or is it merely a temporary fix for a temporary pandemic?Recent FindingsThis global public health emergency has exposed vulnerabilities in our healthcare sy...
Source: Current Allergy and Asthma Reports - Category: Allergy & Immunology Source Type: research
Sex differences in immune responses had been reported to correlate with different symptoms and mortality in the disease course of coronavirus disease 2019 (COVID-19). However, whether severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection interferes with females’ fertility and causes different symptoms among pregnant and non-pregnant females remains unknown. Here, we examined the differences in viral loads, SARS-CoV-2-specific antibody titers, proinflammatory cytokines, and levels of T cell activation after SARS-CoV-2 sub-lethal infection between pregnant and non-pregnant human Angiotensin-Converting En...
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with high infectivity, pathogenicity, and variability, is a global pandemic that severely affected public health and the world economy. The development of safe and effective vaccines is crucial to the prevention and control of an epidemic. As an emerging technology, mRNA vaccine is widely used for infectious disease prevention and control and has significant safety, efficacy, and high production. It has received support and funding from many pharmaceutical enterprises and becomes one of the main technologies for prev...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: African Health | Allergy & Immunology | Brazil Health | Coronavirus | COVID-19 | India Health | Respiratory Medicine | SARS | South Africa Health